Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.

Phillipe MoreauMeletios A DimopoulosPaul G RichardsonDavid S SiegelMichele CavoPaolo CorradiniKatja WeiselMichel DelforgePeter O'GormanKevin SongChristine ChenNizar BahlisAlbert OriolMarkus HanssonMartin KaiserPekka AnttilaReinier RaymakersCristina JoaoGordon CookLars SternasTsvetan BiyukovAna SlaughterKevin HongJennifer HerringXin YuMohamed ZakiJesus San-Miguel

Published in: European journal of haematology (2017)

Pomalidomide plus low-dose dexamethasone showed an acceptable safety profile, and AEs were well managed according to study protocols and established guidelines.

Keyphrases

multiple myeloma
low dose
high dose
acute lymphoblastic leukemia
emergency department